8-K - Inovio Pharmaceuticals, Inc. | StockGist

Current Report Details

Event Type

Material Agreement

Securities Modification

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

Entry into a Material Definitive Agreement. On January 27, 2026, Inovio Pharmaceuticals, Inc. (the “Company”) amended each of its outstanding Series A warrants

Material Agreement

$1.75$1.75

3.03

. Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 4.1 Form of Amendment to the Series A Warrant. 104 Cover Page Interactive D

Securities Modification

Exhibits (2)

4.1

EX-4.1

8-K